XAIMED Co., Ltd. (CEO Sang-min Park) announced that it will participate in CES 2024, which will be held in Las Vegas, USA from Tuesday, January 9 to Friday, January 12, next year (local time).
XAIMED Co., Ltd. (hereinafter referred to as XAIMED) is a leading artificial intelligence medical device company that connects daily life and medicine, AI and people. XAIMED’s eXplainable AI (XAI) technology, which solves the ‘black box’ problem of medical artificial intelligence, provides customized solutions based on medical images, time series biometric data, and structured data. XAIMED, which is expanding its AI product line to urology, laparoscopy, and endoscopy, starting with eye disease AI and arteriosclerosis AI, provides explainable medical AI solutions that provide clearer evidence so that both doctors and patients can trust artificial intelligence. We aim to connect AI and humans by providing
At this exhibition, XAIMED will present the ‘XAI Bio-integrated Sensor Intelligent Solution’ that can check and manage an individual’s health status in daily life.
The ‘XAI Bio-integrated Sensor Intelligent Solution’ integrates fragmented electrocardiographs, thermometers, body composition monitors, blood pressure monitors, and pulse oximeters, and XAIMED is the core of non-invasive measurement technology for diabetes prevention-management-monitoring. We succeeded in developing a miniaturized AGE sensor module and installed it together. The company explained that it is a device that can simultaneously measure vital signs such as heart rate, blood oxygen saturation, skin temperature, body composition, and skin fluorescence advanced glycation end products with just one test (one-stop). It is an all-in-one product that is equipped with a self-developed AI module and firmware, improving inspection performance so that multiple biological signals can be collected simultaneously even with low power.
Additionally, by using fingerprint sensor information, users can be identified when multiple users use one device. This addresses the user integrity, security, and identifiability of the test, allowing organizations to collect reliable data. In addition, the product can be used in real-time telemedicine sites through cloud networking.
A XAIMED official said, “By using the ‘XAI bio-integrated sensor intelligent solution’, people exposed to various environments without medical staff, such as patients with chronic diseases, the elderly population who need continuous health status check, and the medically vulnerable in mountainous islands, can collect biosignals. “It has the advantage of being able to measure easily and monitor health conditions more conveniently in daily life.”
Measurement results can be automatically uploaded through a smartphone or tablet app or the medical device’s own Internet connection. The user-friendly design makes it easy for even digitally vulnerable and elderly people to use it, and accurate and regular measurement results can be expected. In addition, we are developing an AI-based intelligent monitoring system that can provide real-time analysis results to patients in the form of smartphone notifications or voice narration.
Currently, XAIMED is in the process of further stabilizing the ‘XAI Bio-integrated Sensor Intelligent Solution’ by repeating demonstrations and tests with the initial production products delivered to each institution and company. In addition, sales of the product are being actively discussed as various demand sources have emerged, and sales are reportedly increasing with the start of domestic pilot sales in earnest.
In the case of medical use, the product has been introduced and used on a pilot basis at medical centers to manage the health of residents in medically vulnerable areas in mountainous and remote areas of Korea. We are conducting joint research using the local budget, and based on the data collected through this product, we are evaluating the usability of the product and verifying the effectiveness of application in medical fields. In the case of industrial use, construction companies are installing and operating them at construction sites in three regions in Korea: Songdo, Busan, and Goseong to manage the health of field workers.
As such, field tests are being conducted in various places in Korea for the initial production products, and the next product with improvements is scheduled to be released and officially sold in 2024. In the case of this product, the main users are the elderly population who need continuous management of their personal health, so XAIMED is preparing to enter countries such as Japan and the United States where the population is rapidly aging.
In relation to this, an official said, “In the United States, it is a huge financial burden for patients without private insurance to visit the hospital, so it may be difficult for medically underprivileged groups to receive even simple health checkups. Therefore, launching a product that allows the elderly or chronically ill to continuously check their personal health status and observe changes at home could be an effective solution to enable low-cost health care from a long-term perspective.” He said
He continued, “The primary target market for ‘XAI Bio-Integrated Sensor Intelligent Solution’ is home wellness products. The secondary target market is to obtain domestic and foreign approvals and release them as medical devices, and share various bio-signals obtained through this product with family, institutions, hospitals, etc. to monitor the user’s health status and present a new paradigm for health management.” He elaborated.
To this end, XAIMED has already developed a non-invasive advanced glycation end product (AGE) sensor miniaturization module that can be mounted on wearable devices (smartwatches for diabetes prevention-management-monitoring, etc.) based on its small size and low power consumption. It is planned to be applied.
Meanwhile, ‘CES’, the world’s largest IT exhibition hosted by the Consumer Technology Association (CTA), is an exhibition where you can see the flow of innovative technologies around the world at a glance and is held every January in Las Vegas, USA. AVING News, which has covered CES for 18 consecutive years, has reported CES news around the world every year since 2006, and has been selected through ‘BEST OF CES’ and ‘BEST OF MADE IN KOREA’, which select the best innovative products, companies and technologies. has been in progress. In addition, CES on-site issues are vividly conveyed through ‘AVING LIVE’.
The CES 2024 Seoul Unified Hall will be operated at the largest scale in terms of exhibition area, number of participating companies, and number of participating supporters since Seoul City’s first participation in CES in 2020. The Seoul Integration Center, in which 13 organizations collaborate and participate, is an important step in Seoul’s efforts to make Seoul a mecca for startups, and 17 of the companies participating in the Seoul Integration Center proved this by receiving innovation awards. The participating institutions in the Seoul Unification Center are ▲SBA ▲Seoul Bio Hub ▲Campus Town ▲AI Yangjae Hub ▲Gwanak-gu ▲Yonsei University ▲Korea University ▲Chung-Ang University ▲Sogang University ▲Kookmin University ▲Hanyang University ▲Konkuk University ▲Kyunghee University. Not only the Seoul Metropolitan Government, institutions, and companies, but also supporters through industry-academia cooperation are matched 1:1 with companies, and 85 supporters, the largest number, will participate.
* Special reporters: Joseph Choe, Kidai Kim, Dongkwan Kim, Mokkyung Lee, Sangun Choi, Seung Hyun Nam, Sunghwan Kim, Taeuck Lim, Min Choi
→ Go to the CES 2024 news special page